47 related articles for article (PubMed ID: 7930570)
1. Simultaneous activation of Ig and Oct-2 synthesis and reduction of surface MHC class II expression by IL-6.
Natkunam Y; Zhang X; Liu Z; Chen-Kiang S
J Immunol; 1994 Oct; 153(8):3476-84. PubMed ID: 7930570
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta suppresses human B lymphocyte Ig production by inhibiting synthesis and the switch from the membrane form to the secreted form of Ig mRNA.
Kehrl JH; Thevenin C; Rieckmann P; Fauci AS
J Immunol; 1991 Jun; 146(11):4016-23. PubMed ID: 1903417
[TBL] [Abstract][Full Text] [Related]
3. Memory, but not naive, peripheral blood B lymphocytes differentiate into Ig-secreting cells after CD40 ligation and costimulation with IL-4 and the differentiation factors IL-2, IL-10, and IL-3.
Kindler V; Zubler RH
J Immunol; 1997 Sep; 159(5):2085-90. PubMed ID: 9278293
[TBL] [Abstract][Full Text] [Related]
4. CD40-dependent and -independent activation of human tonsil B cells by CpG oligodeoxynucleotides.
Gantner F; Hermann P; Nakashima K; Matsukawa S; Sakai K; Bacon KB
Eur J Immunol; 2003 Jun; 33(6):1576-85. PubMed ID: 12778475
[TBL] [Abstract][Full Text] [Related]
5. Differential involvement of the transcription factor Blimp-1 in T cell-independent and -dependent B cell differentiation to plasma cells.
Soro PG; Morales-A P; Martínez-M JA; Morales-A S; Copín SG; Marcos MA; Gaspar ML
J Immunol; 1999 Jul; 163(2):611-7. PubMed ID: 10395648
[TBL] [Abstract][Full Text] [Related]
6. Limited expression of C/EBP family proteins during B lymphocyte development. Negative regulator Ig/EBP predominates early and activator NF-IL-6 is induced later.
Cooper CL; Berrier AL; Roman C; Calame KL
J Immunol; 1994 Dec; 153(11):5049-58. PubMed ID: 7963564
[TBL] [Abstract][Full Text] [Related]
7. Induction of differentiation-regulated transcription factor Oct-6 specifically accompanies major histocompatibility complex class I down-regulation by E1A of oncogenic adenovirus type 12.
Peeper DS; Schouten GJ; Toebes M; Meijer D; Zwart R; van de Woude I; van Schaik H; van der Eb AJ; Zantema A
Cell Growth Differ; 1995 Aug; 6(8):977-84. PubMed ID: 8547226
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of IL-10 protein synthesis induces major histocompatibility complex class II gene expression in class II-deficient patients.
Hauber I; Wolf HM; Samstag A; Pein B; Kreil TR; Gulle H; Fischer MB; Eibl MM
Cell Immunol; 1997 Sep; 180(2):95-103. PubMed ID: 9341739
[TBL] [Abstract][Full Text] [Related]
9. IL-1 beta inhibits IFN-gamma-induced class II MHC expression by suppressing transcription of the class II transactivator gene.
Rohn W; Tang LP; Dong Y; Benveniste EN
J Immunol; 1999 Jan; 162(2):886-96. PubMed ID: 9916712
[TBL] [Abstract][Full Text] [Related]
10. A potential role for adrenocorticotropin in regulating human B lymphocyte functions.
Alvarez-Mon M; Kehrl JH; Fauci AS
J Immunol; 1985 Dec; 135(6):3823-6. PubMed ID: 2999232
[TBL] [Abstract][Full Text] [Related]
11. Cooperation of binding sites for STAT6 and NF kappa B/rel in the IL-4-induced up-regulation of the human IgE germline promoter.
Messner B; Stütz AM; Albrecht B; Peiritsch S; Woisetschläger M
J Immunol; 1997 Oct; 159(7):3330-7. PubMed ID: 9317131
[TBL] [Abstract][Full Text] [Related]
12. B lymphocyte development and activation independent of MHC class II expression.
Markowitz JS; Rogers PR; Grusby MJ; Parker DC; Glimcher LH
J Immunol; 1993 Feb; 150(4):1223-33. PubMed ID: 8432977
[TBL] [Abstract][Full Text] [Related]
13. Cross-linking of MHC class II molecules with anti-MHC class II antibody or epitope peptide prevents resting B lymphocyte differentiation by inhibiting NF-kappaB-dependent gene expression.
Kim J; Kim HR; Bae JL; Kim DH; Ki HJ; Lee HK; Choi SH; Jang YS
Mol Cells; 2001 Aug; 12(1):67-76. PubMed ID: 11561732
[TBL] [Abstract][Full Text] [Related]
14. Redundant and unique regulation of activated mouse B lymphocytes by IL-4 and IL-21.
Jin H; Malek TR
J Leukoc Biol; 2006 Dec; 80(6):1416-23. PubMed ID: 16943384
[TBL] [Abstract][Full Text] [Related]
15. CD27/CD70 interaction augments IgE secretion by promoting the differentiation of memory B cells into plasma cells.
Nagumo H; Agematsu K; Shinozaki K; Hokibara S; Ito S; Takamoto M; Nikaido T; Yasui K; Uehara Y; Yachie A; Komiyama A
J Immunol; 1998 Dec; 161(12):6496-502. PubMed ID: 9862673
[TBL] [Abstract][Full Text] [Related]
16. Adenovirus vector-mediated overexpression of a truncated form of the p65 nuclear factor kappa B cDNA in dendritic cells enhances their function resulting in immune-mediated suppression of preexisting murine tumors.
Lee JM; Mahtabifard A; Yamada R; Crystal RG; Korst RJ
Clin Cancer Res; 2002 Nov; 8(11):3561-9. PubMed ID: 12429647
[TBL] [Abstract][Full Text] [Related]
17. IL-10 inhibits T cell-independent but not T cell-dependent responses in vitro.
Peçanha LM; Snapper CM; Lees A; Yamaguchi H; Mond JJ
J Immunol; 1993 Apr; 150(8 Pt 1):3215-23. PubMed ID: 8468466
[TBL] [Abstract][Full Text] [Related]
18. The B cell coactivator Bob1 shows DNA sequence-dependent complex formation with Oct-1/Oct-2 factors, leading to differential promoter activation.
Gstaiger M; Georgiev O; van Leeuwen H; van der Vliet P; Schaffner W
EMBO J; 1996 Jun; 15(11):2781-90. PubMed ID: 8654375
[TBL] [Abstract][Full Text] [Related]
19. Monomeric IgG2 enhances Ig production and proliferation in human B cells.
Kimata H; Yoshida A; Ishioka C; Jiang Y; Kusunoki T; Mikawa H
Biotechnol Ther; 1993; 4(1-2):1-16. PubMed ID: 8374507
[TBL] [Abstract][Full Text] [Related]
20. HIV-gp 160-induced T cell-dependent B cell differentiation. Role of T cell-B cell activation molecule and IL-6.
Chirmule N; Kalyanaraman VS; Lederman S; Oyaizu N; Yagura H; Yellin MJ; Chess L; Pahwa S
J Immunol; 1993 Mar; 150(6):2478-86. PubMed ID: 8450224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
